Definitive Healthcare Corp. (NASDAQ:DH) Stock Has Consensus Price Target of $1.47 According to Brokerages

Definitive Healthcare Corp. (NASDAQ:DH) has been given a consensus rating of “Reduce” by the nine analysts that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $1.47.

Several brokerages have recently commented on DH. Wall Street Zen raised Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Sunday, September 13th. Weiss Ratings raised Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $1.00 price objective on shares of Definitive Healthcare in a research note on Wednesday, August 12th. BTIG Research reissued a “neutral” rating on shares of Definitive Healthcare in a research note on Friday, September 4th. Finally, Morgan Stanley decreased their price objective on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating for the company in a research report on Tuesday, August 11th.

Hedge Funds Weigh In On Definitive Healthcare

A number of large investors have recently made changes to their positions in DH. Jefferies Financial Group Inc. acquired a new stake in shares of Definitive Healthcare during the third quarter worth approximately $90,000. Williams & Novak Wealth Management LLC grew its position in Definitive Healthcare by 15.3% during the third quarter. Williams & Novak Wealth Management LLC now owns 90,610 shares of the company’s stock valued at $82,000 after purchasing an additional 12,000 shares in the last quarter. Squarepoint Ops LLC increased its stake in Definitive Healthcare by 46.5% in the 2nd quarter. Squarepoint Ops LLC now owns 351,575 shares of the company’s stock valued at $292,000 after buying an additional 111,634 shares during the period. Corient Private Wealth LP acquired a new position in Definitive Healthcare in the 2nd quarter valued at approximately $378,000. Finally, Williams & Novak LLC increased its stake in Definitive Healthcare by 155.8% in the 2nd quarter. Williams & Novak LLC now owns 78,610 shares of the company’s stock valued at $65,000 after buying an additional 47,880 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH opened at $1.15 on Wednesday. The firm has a 50 day simple moving average of $1.02 and a 200 day simple moving average of $1.06. Definitive Healthcare has a 52 week low of $0.61 and a 52 week high of $3.00. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.86 and a current ratio of 1.86. The company has a market cap of $123.23 million, a PE ratio of -0.77, a price-to-earnings-growth ratio of 14.19 and a beta of 1.39.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Definitive Healthcare had a negative net margin of 69.18% and a positive return on equity of 4.07%. The firm had revenue of $54.65 million for the quarter, compared to analysts’ expectations of $54.58 million. As a group, research analysts expect that Definitive Healthcare will post 0.06 earnings per share for the current year.

About Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.